bromocriptine has been researched along with perphenazine in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (44.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 5 (20.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jadhav, A; Kerns, E; Nguyen, K; Shah, P; Sun, H; Xu, X; Yan, Z; Yu, KR | 1 |
| Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
| Kabir, M; Kerns, E; Neyra, J; Nguyen, K; Nguyễn, ÐT; Shah, P; Siramshetty, VB; Southall, N; Williams, J; Xu, X; Yu, KR | 1 |
| Gala, RR; Jaques, S | 1 |
| Boyns, AR; Brownstone, AD; Jones, GE | 1 |
| Bernton, E; Bryant, H; Dave, J; Holaday, J | 1 |
| Cornelisse, CJ; Keijzer, R; van de Velde, CJ; van Dierendonck, JH; Wijsman, JH | 1 |
| Anthony, RV; Ireland, FA; Loch, WE; Worthy, K | 1 |
| Jacobsen, BP; Sinha, YN | 2 |
| Garg, SK; Kulkarni, SK; Mathur, VS; Shukla, VK | 1 |
| Arafah, BM; Finegan, HM; Manni, A; Pearson, OH; Rainieri, J | 1 |
| Buckman, MT; Mattox, JH; Peake, GT | 1 |
| Krall, A; Spring-Mills, E | 2 |
| Apellaniz, M; Krall, A; Spring-Mills, E | 1 |
| Callaghan, JT; Crabtree, R; Lemberger, L | 1 |
| Iishi, H; Kanda, Y; Koike, K; Miyake, A; Tatsuta, M; Terada, N; Tsuji, M; Yamamoto, R; Yamamoto, T | 1 |
| Bennett-Wimbush, K; Evans, T; Loch, WE; Plata-Madrid, H | 1 |
1 review(s) available for bromocriptine and perphenazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
24 other study(ies) available for bromocriptine and perphenazine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Highly predictive and interpretable models for PAMPA permeability.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Humans; Models, Biological; Organic Chemicals; Regression Analysis; Support Vector Machine | 2017 |
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |
Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
Topics: Animals; Computer Simulation; Databases, Factual; Drug Discovery; High-Throughput Screening Assays; Liver; Machine Learning; Male; Microsomes, Liver; National Center for Advancing Translational Sciences (U.S.); Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Retrospective Studies; United States | 2020 |
The influence of 2 br-alpha-ergocryptine (CB-154) and apomorphine on induced prolactin secretion in the crab eating monkey (Macaca fascicularis).
Topics: Animals; Apomorphine; Bromocriptine; Castration; Ergolines; Female; Humans; Macaca fascicularis; Ovary; Perphenazine; Prolactin; Radioimmunoassay; Thyrotropin-Releasing Hormone; Time Factors | 1975 |
Isolation of canine prolactin by polyacrylamide gel electrophoresis.
Topics: Animals; Bromocriptine; Chlorpromazine; Dogs; Electrophoresis, Polyacrylamide Gel; Estrus; Female; Male; Perphenazine; Pituitary Gland; Pregnancy; Prolactin; Radioimmunoassay | 1976 |
Prolactin and prolactin secretagogues reverse immunosuppression in mice treated with cysteamine, glucocorticoids, or cyclosporin-A.
Topics: Adrenocorticotropic Hormone; Animals; Bromocriptine; Corticosterone; Cyclosporine; Cysteamine; Glucocorticoids; Hemolytic Plaque Technique; Lymphocyte Activation; Male; Metoclopramide; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Perphenazine; Pituitary-Adrenal System; Prolactin; Spleen | 1992 |
A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.
Topics: Animals; Bromocriptine; Cell Division; DNA, Neoplasm; Drug Implants; Estradiol; Female; Flow Cytometry; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neoplasm Regression, Spontaneous; Neoplasm Transplantation; Perphenazine; Ploidies; Prolactin; Rats; Rats, Inbred Strains | 1991 |
Effects of bromocriptine and perphenazine on prolactin and progesterone concentrations in pregnant pony mares during late gestation.
Topics: Animals; Bromocriptine; Dystocia; Female; Horses; Lactation; Perphenazine; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Time Factors | 1991 |
Structural and immunologic evidence for a small molecular weight ("21K") variant of prolactin.
Topics: Animals; Bromocriptine; Estradiol; Female; Genetic Variation; Lactation; Male; Mice; Mice, Inbred Strains; Molecular Weight; Ovariectomy; Peptide Mapping; Perphenazine; Pituitary Gland; Pregnancy; Progesterone; Prolactin; Rats; Rats, Inbred Strains; Reference Values | 1988 |
Glycosylated prolactin in the murine pituitary: detection by a novel assay and alteration of concentrations by physiological and pharmacological stimuli.
Topics: Animals; Bromocriptine; Estradiol; Female; Immunoassay; Lactation; Lectins; Mice; Mice, Inbred Strains; Molecular Weight; Ovariectomy; Perphenazine; Pituitary Gland; Pregnancy; Progesterone; Prolactin; Rats; Rats, Inbred Strains; Testosterone | 1987 |
GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats.
Topics: Animals; Bromocriptine; Catatonia; Dopamine; Drug Synergism; GABA Antagonists; gamma-Aminobutyric Acid; Injections, Intraventricular; Male; Muscimol; Parasympatholytics; Perphenazine; Piracetam; Rats; Rats, Inbred Strains; Scopolamine; Time Factors; Valproic Acid | 1985 |
Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
Topics: Animals; Bromocriptine; Castration; Estradiol; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Perphenazine; Prolactin; Rats; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Prolactin; Tamoxifen | 1982 |
The value of prolactin dynamics as a predictor of ovulation with bromocriptine in patients with polycystic ovary syndrome.
Topics: Adult; Bromocriptine; Circadian Rhythm; Drug Administration Schedule; Female; Humans; Ovulation; Ovulation Induction; Perphenazine; Polycystic Ovary Syndrome; Prognosis; Prolactin | 1984 |
Effects of perphenazine and bromocriptine on male accessory sex glands. III. The prostate gland.
Topics: Animals; Bromocriptine; Castration; Male; Mice; Mice, Inbred C3H; Perphenazine; Prostate; Testosterone | 1982 |
Effects of bromocriptine and perphenazine on male accessory sex glands II. Ultrastructure of the seminal vesicles.
Topics: Animals; Bromocriptine; Castration; Cytoplasmic Granules; Endoplasmic Reticulum; Golgi Apparatus; Male; Mice; Mice, Inbred C3H; Microscopy, Electron; Perphenazine; Prolactin; Seminal Vesicles; Testosterone | 1982 |
Pergolide, a potent long-acting dopamine-receptor agonist.
Topics: Adult; Blood Pressure; Bromocriptine; Circadian Rhythm; Dose-Response Relationship, Drug; Ergolines; Ergot Alkaloids; Growth Hormone; Hormones; Humans; Male; Middle Aged; Myocardial Contraction; Pergolide; Perphenazine; Prolactin; Receptors, Dopamine; Time Factors | 1980 |
Effects of bromocriptine and perphenazine on male accessory sex glands. I. The seminal vesicles.
Topics: Animals; Bromocriptine; Castration; Male; Mice; Perphenazine; Seminal Vesicles; Testosterone | 1981 |
Correlation between serum prolactin levels and hepatocellular tumorigenesis induced by 3'-methyl-4-dimethylaminoazobenzene in mice.
Topics: Adenoma; Animals; Bromocriptine; Estrogens; Female; Liver Neoplasms, Experimental; Methyldimethylaminoazobenzene; Mice; Mice, Inbred C57BL; Perphenazine; Pituitary Gland; Prolactin | 1995 |
The effects of perphenazine and bromocriptine on follicular dynamics and endocrine profiles in anestrous pony mares.
Topics: Anestrus; Animals; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Estradiol; Female; Follicle Stimulating Hormone; Horses; Male; Ovarian Follicle; Ovary; Ovulation; Perphenazine; Prolactin; Time Factors | 1998 |